Yahoo
XETRA - Delayed Quote EUR

Redcare Pharmacy NV (RDC.DE)

69.60 -4.70 (-6.33%)
At close: October 30 at 5:35:13 PM GMT+1
RDC.DE Q3 2026 earnings call
Replay the call for the latest insights.
Chart Range Bar
Loading chart for RDC.DE
  • Previous Close 74.30
  • Open 73.90
  • Bid 69.60 x --
  • Ask 69.35 x --
  • Day's Range 69.05 - 73.90
  • 52 Week Range 30.20 - 79.90
  • Volume 112,887
  • Avg. Volume 84,548
  • Market Cap (intraday) 1.404B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -1.69
  • Earnings Date Oct 29, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 91.00

Redcare Pharmacy NV operates the online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It offers prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare Pharmacy NV was founded in 2001 and is based in Sevenum, the Netherlands.

www.redcare-pharmacy.com

2,163

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

RDC.DE
6.91%
DAX P (^GDAXI)
5.42%

1-Year Return

RDC.DE
3.06%
DAX P (^GDAXI)
7.05%

3-Year Return

RDC.DE
32.88%
DAX P (^GDAXI)
75.44%

5-Year Return

RDC.DE
46.87%
DAX P (^GDAXI)
64.56%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 847M
Earnings 1M
Profit Margin 0.12%

Q3

FY25

Q4

FY25

Q2

FY26

Q3

FY26

0
200M
400M
600M
800M
-1.0%
-0.5%
0.0%
0.5%

Analyst Insights

View More

Analyst Price Targets

72.00
91.00 Average
69.60 Current
120.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.01%

  • Return on Assets (ttm)

    0.51%

  • Return on Equity (ttm)

    -7.06%

  • Revenue (ttm)

    3.34B

  • Net Income Avi to Common (ttm)

    -33.96M

  • Diluted EPS (ttm)

    -1.69

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    132.4M

  • Total Debt/Equity (mrq)

    74.40%

  • Levered Free Cash Flow (ttm)

    -61.89M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: